Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Natural Product Can Boost Animal Immune Health

(Agricultural Research Service, USDA)

31 October 2014. Tests by Avivagen Inc. show an ability of beta-carotene to spontaneously oxidize that offers a natural alternative to antibiotics added to livestock feed to reduce illness and gain weight. The researchers from Avivagen, an animal health products company in Ottawa, Canada and National Research Council of Canada . . . → Read More: Natural Product Can Boost Animal Immune Health

Ebola-Marburg Vaccine Development, Testing Contract Awarded

Ebola health care workers in Guinea (European Commission-ECHO/USIAD)

31 October 2014. A biodefense unit of the U.S. Department of Defense awarded a contract to vaccine maker Profectus BioSciences Inc. for development and testing of a vaccine protecting against the two major Ebola strains and related Marburg viruses. The $9.5 million contract with the Baltimore . . . → Read More: Ebola-Marburg Vaccine Development, Testing Contract Awarded

Drug/Device Therapy Trial Shows Fast Migraine Relief

(R. Nial Bradshaw, Flickr)

30 October 2014. A late-stage clinical trial shows a medical device designed to deliver migraine drugs deep into nasal cavities achieved headache relief in as little as 30 minutes among patients, and sustained that relief for as long as 48 hours compared to a placebo. The biopharmaceutical company Avanir Pharmaceuticals . . . → Read More: Drug/Device Therapy Trial Shows Fast Migraine Relief

Synthetic Blood Thinner Antidote Developed

(National Institutes of Health)

30 October 2014. Medical and biochemical researchers at University of British Columbia in Vancouver, Canada designed a polymer antidote for heparin that in lab animals neutralizes anti-coagulant activity and appears to be well tolerated. The team led by chemistry and pathology professor Jayachandran Kizhakkedathu published its findings yesterday in the . . . → Read More: Synthetic Blood Thinner Antidote Developed

Taking a break

(A. Kotok)

26 October 2014. Science & Enterprise is taking a break from blogging for a few days. We’ll return on Thursday, 30 October.

* * *

Please share Science & Enterprise …

Costs to Support Stroke Survivors Stay High for 10 Years

Dominique Cadilhac (Monash University)

24 October 2014. Researchers at Monash University in Australia calculated long-term costs to stroke patients, finding the financial burden on patients and their care givers remains significant for 10 years following the stroke episode. The team led by Monash medical school professor Dominique Cadilhac reported its findings in yesterday’s issue . . . → Read More: Costs to Support Stroke Survivors Stay High for 10 Years

Paper-Based Synthetic Bio Sensors, Circuits Developed

Paper strip with color-indicated proteins (Wyss Institute, Harvard University)

24 October 2014. Biomedical engineers at Harvard University designed systems with simple sensors applied on paper to detect complex cellular reactions that can speed use of point-of-care diagnostics in the field. Findings from the team at Harvard’s Wyss Institute for Biologically Inspired Engineering, with colleagues . . . → Read More: Paper-Based Synthetic Bio Sensors, Circuits Developed

Biotech, McGill Univ Partner on Soil Enhancement Microbes

Soybean field (Agricultural Research Service/USDA)

23 October 2014. Inocucor Technologies Inc. and McGill University are collaborating on development of new types of microbes that improve soil for greater yields of large-scale crops such as corn and soybeans. Financial details of the research and licensing agreement between the company and university, both in Montreal, Quebec, . . . → Read More: Biotech, McGill Univ Partner on Soil Enhancement Microbes

IBM, Health Tech, Univ Designing Critical Care Mobile System

(Photos8.com)

23 October 2014. IBM, University of Michigan, and mobile health technology company AirStrip are developing a system to provide real time monitoring and analytics for patients with chronic or critical disorders. The system is being designed to collect data directly from patients and provide early warning initially for hemodynamic decompensation, a type of . . . → Read More: IBM, Health Tech, Univ Designing Critical Care Mobile System

Clinical Trial Proposals Sought for ALS Treatments

3-D brain wiring illustration (NIH)

22 October 2014. A group of U.S. organizations promoting research on therapies for amyotrophic lateral sclerosis or ALS are seeking proposals from academic-industry research teams for intermediate stage clinical trials to test treatment candidates for the disease. The organizations — ALS Association, ALS Accelerated Therapeutics or ALS ACT, and . . . → Read More: Clinical Trial Proposals Sought for ALS Treatments